PA Prescribing 2026: Current Status, Political Landscape, and Preparation

Featured image for PA Prescribing 2026: Current Status, Political Landscape, and Preparation

PA prescribing is one of the most contested issues in UK healthcare — and the landscape is evolving.

Current status: PAs cannot independently prescribe in the UK. They can request and recommend medications under supervision but cannot sign prescriptions.

GMC regulation: Provides the professional framework that could support future prescribing legislation — but regulation alone does not grant prescribing rights. Separate legislation is required.

Political context: Significant opposition from medical profession bodies. Ongoing debate about patient safety, scope creep, and workforce planning. PAs should be aware of the debate without being consumed by it.

Building prescribing knowledge: Regardless of current prescribing status, strong pharmacological knowledge (BNF, clinical therapeutics, drug interactions, monitoring) is essential for safe clinical practice — and positions PAs for any future prescribing changes.

iatroX builds the pharmacological and clinical knowledge underpinning safe practice — the same knowledge base that prescribing would require.

Share this insight